YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.

Browsing by Author "Sertogullarindan, Buenyamin"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Article
    A Case of Miliary Tuberculosis, Pneumothorax, and Pulmonary Thromboembolism: Original Image
    (Ortadogu Ad Pres & Publ Co, 2009) Ozbay, Bulent; Sertogullarindan, Buenyamin; Asker, Selvi; Ekin, Selami; Yildiz, Hanifi; Sunnetcioglu, Mahmut
    A 30 years old woman complained of high fever and dyspnea. She delivered her 7(th) child 4 weeks ago. Symptoms had started after delivery and increased during the last 3 days. PA chest roentgenogram showed diffuse and bilateral miliary nodules. Physical examination revealed temperature 39.2 degrees C, pulse 130/min, arterial tension 90/60 mmHg, respiratory rate 35/min, and lung sounds normal. Deep venous thrombosis was detected in the right leg. SaO(2) was 69% and PaO2/FiO(2) was 86 while on 6 L/min O-2 inhalation. Computed tomography of thorax showed filling defects as well as miliary nodules. The tuberculin skin reaction was positive. Bilateral tuberculosis foci were seen in the choroid of retina. Treatment consisted of antituberculous drugs, anticoagulants, fluid and nutritional support. PaO2/FiO(2) rapidly improved. Recurrent pneumothorax developed. A tube thoracostomy was inserted. This case was interesting regarding the coexistence of miliary tuberculosis, recurrent pnomothorax, and venous thromboembolism.
  • Thumbnail Image
    Article
    Clinical Characteristics of Covid-19 Patients in Abo Blood Groups
    (Kare Publ, 2024) Dogan, Celal; Sertogullarindan, Buenyamin; Turan, Muzaffer Onur; Anar, Ceyda; Uzun, Berrin; Soyguder, Suleyman
    BACKGROUND AND AIM: Coronavirus Disease 2019 (COVID-19) is a novel respiratory infection caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Recent studies have suggested that certain blood groups may be associated with different risks of COVID-19 infection and mortality. METHODS: We conducted a retrospective case-control study to determine if ABO blood groups are associated with different clinical outcomes. Our study involved 286 COVID-19 patients. RESULTS: We found that patients with the AB blood group had a higher risk of COVID-19 compared to the control group (OR=3.63, 95% CI=2.76-4.76, p<0.0001). Conversely, patients with the O blood group had a higher risk of death (OR=9.56, 95% CI=3.059-27.89, p=0.001). White blood cell (WBC) counts, C-reactive protein (CRP) levels, and the Neutrophil to Lymphocyte ratio (NLR) varied among ABO blood groups. Comparing fatal to survival cases, we observed that fatal cases had higher levels of WBC, CRP, and NLR in comparison to survivors. Multiple logistic regression analysis revealed that age, O blood group, and NLR were independent factors for mortality. CONCLUSIONS: ABO blood groups can exhibit different clinical characteristics. Nonetheless, it is crucial to emphasize that elevated inflammation markers and advanced age are also independent risk factors for mortality. Further studies with larger populations are essential to fully comprehend the relationship between ABO blood groups and COVID-19 outcomes.